Gene · 4928
Papers2,783
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,783
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diesel exhaust exposure alters the expression of networks implicated in neurodegeneration in zebrafish brains. | Cell Biol Toxicol | 2023 | 34057650 | PubTator, text mining | PubMed |
| Recognition of Histone H3 Methylation States by the PHD1 Domain of Histone Demethylase KDM5A. | ACS Chem Biol | 2023 | 33621062 | PubTator, text mining | PubMed |
| Acute promyelocytic leukemia with FIP1L1::RARA fusion gene: The clinical utility of transcriptome sequencing and bioinformatic analyses. | Front Oncol | 2022 | 36776354 | PubTator, text mining | PubMed |
| The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions. | Front Oncol | 2022 | 36741714 | PubTator, text mining | PubMed |
| Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement. | Front Oncol | 2022 | 36713535 | PubTator, text mining | PubMed |
| [Chinese expert consensus of the allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia (not APL) (2022)]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709193 | PubTator, text mining | PubMed |
| [Advances in the recognition of acute myeloid leukemia with RARG-rearrangement]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709143 | PubTator, text mining | PubMed |
| Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies. | Biomolecules | 2022 | 36671446 | PubTator, text mining | PubMed |
| An Overview of 10th Anniversary of Cells-Advances in Cell Nuclei: Function, Transport and Receptors. | Cells | 2022 | 36611849 | PubTator, text mining | PubMed |
| Nuclear envelope, chromatin organizers, histones, and DNA: The many achilles heels exploited across cancers. | Front Cell Dev Biol | 2022 | 36589746 | PubTator, text mining | PubMed |
| Upfront Screening by Quantitative Real-Time PCR Assay Identifies NUP98::NSD1 Fusion Transcript in Indian AML Patients. | Diagnostics (Basel) | 2022 | 36553008 | PubTator, text mining | PubMed |
| Leukemic stem cells and advances in hematopoietic stem cell transplantation for acute myeloid leukemia: a narrative review of clinical trials. | Stem Cell Investig | 2022 | 36540355 | PubTator, text mining | PubMed |
| The dynamics of three-dimensional chromatin organization and phase separation in cell fate transitions and diseases. | Cell Regen | 2022 | 36539553 | PubTator, text mining | PubMed |
| Identification of molecular subtypes based on liquid-liquid phase separation and cross-talk with immunological phenotype in bladder cancer. | Front Immunol | 2022 | 36518754 | PubTator, text mining | PubMed |
| Cardiovirus leader proteins retarget RSK kinases toward alternative substrates to perturb nucleocytoplasmic traffic. | PLoS Pathog | 2022 | 36508477 | PubTator, text mining | PubMed |
| The emerging role of DEAD/H-box helicases in hepatitis B virus infection. | Front Cell Infect Microbiol | 2022 | 36506030 | PubTator, text mining | PubMed |
| Pore performance: artificial nanoscale constructs that mimic the biomolecular transport of the nuclear pore complex. | Nanoscale Adv | 2022 | 36504753 | PubTator, text mining | PubMed |
| Protein Phase Separation: New Insights into Carcinogenesis. | Cancers (Basel) | 2022 | 36497453 | PubTator, text mining | PubMed |
| Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy. | Mol Neurodegener | 2022 | 36482422 | PubTator, text mining | PubMed |
The anterior gradient homologue 2 (AGR2) co-localises with the glucose-regulated protein 78 (GRP78) in cancer stem cells, and is critical for the survival and drug resistance of recurrent glioblastoma: in situ and in vitro analyses. | Cancer Cell Int | 2022 | 36482387 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4928/papers?page=27